Delivery Order SPE2DB20D6035-SPE2DB24FD1RX
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $2,028.78 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4564244773 CONTRAVE ER 8-90 MG TABLET 120S. This delivery order falls under a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, with a ceiling value of $23,604.03 and a final completion date of June 25, 2024. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award, valued at $7,502.40, is for the delivery of 4,564,054,637 CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The order is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, with a potential value of $4,278.69 and a completion date of February 8, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00, which serves as the primary...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a subsidiary of AmerisourceBergen Corporation. The delivery order is for the pharmaceutical product CONTRAVE ER 8-90 MG TABLET 120S, with a ceiling value of $8,787.25. The contract is a firm fixed price contract with an ultimate completion date of April 4, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,397.26, is for the procurement of CONTRAVE ER 8-90 MG TABLET 120S, a prescription medication. The contract has an ultimate completion date of February 26, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CONTRAVE ER 8-90 MG TABLET 120S. The contract has a firm fixed price of $2,827.52 and an ultimate completion date of June 18, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a comprehensive global...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The order is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a prescription medication. The contract has a potential value of $4,923.68 and a period of performance through March 8, 2024. This order is not set-aside and is part of a larger indefinite delivery contract (IDC) valued...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of CONTRAVE ER 8-90 MG Tablet 120S. The delivery order has a ceiling value of $11,177.29 and a period of performance through April 3, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. The delivery order is issued under a larger...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The order has a ceiling value of $8,109.36 and an ultimate completion date of July 22, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive...
- SPE2DB20D6035Indefinite Delivery Contract
- SPE2DB20D6035-SPE2DB24FD1RXDelivery Order
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, with a potential value of $3,751.20 and a performance period through February 6, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp holds with DLA, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this specific delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 2/5/24 |